Skip to content

LIVE

Supreme Court refuses to order ‘full public disclosure’ of ultimate beneficiaries of AIFs, FPIs without ‘legal framework’◆Inflation surges, PCE shows. Fed pause on rate hikes unlikely to last long with prices still rising.◆U.S. Economy Expands at Fastest Rate in Nearly Three Years, Third‑Quarter GDP Shows◆Patna High Court Quashes Rape Case on Grounds of Unsubstantiated Allegations◆Kerala High Court Demands Names for Task Force to Combat Munnar Land Encroachments◆Caterpillar’s stock heads for worst day in 7 years — and what that means for the Dow◆Himachal Pradesh Doubles Milk Incentive to Rs 6 per Litre in Rural Support Drive◆Southern California's trick-or-treaters may need an umbrella on Halloween! Rainy weekend ahead - CBS News◆Supreme Court refuses to order ‘full public disclosure’ of ultimate beneficiaries of AIFs, FPIs without ‘legal framework’◆Inflation surges, PCE shows. Fed pause on rate hikes unlikely to last long with prices still rising.◆U.S. Economy Expands at Fastest Rate in Nearly Three Years, Third‑Quarter GDP Shows◆Patna High Court Quashes Rape Case on Grounds of Unsubstantiated Allegations◆Kerala High Court Demands Names for Task Force to Combat Munnar Land Encroachments◆Caterpillar’s stock heads for worst day in 7 years — and what that means for the Dow◆Himachal Pradesh Doubles Milk Incentive to Rs 6 per Litre in Rural Support Drive◆Southern California's trick-or-treaters may need an umbrella on Halloween! Rainy weekend ahead - CBS News◆

Home / Global Markets

Global Markets

Lilly raised sales guidance for third time this year as Zepbound sales soar. Its stock is rallying.

The drugmaker continues to dominate the market for prescription weight-loss drugs in the U.S.

MarketWatchOctober 29, 20261 min read

Lilly raised sales guidance for third time this year as Zepbound sales soar. Its stock is rallying.

The drugmaker continues to dominate the market for prescription weight-loss drugs in the U.S.

📡 Verified Wire Agency Verified Resource & Provenance

Original Resource

Read Wire Dispatch → Share on 𝕏

✉

The Next Brief

Get the day's most important stories in one email

AI-curated morning digest. No noise. Unsubscribe anytime.

Comments 0

No comments yet. Start the conversation.

Advertisement

Related stories

Inflation surges, PCE shows. Fed pause on rate hikes unlikely to last long with prices still rising.

MarketWatch · October 29, 2026

Caterpillar’s stock heads for worst day in 7 years — and what that means for the Dow

MarketWatch · October 29, 2026

It’s the strangest job market the U.S. has ever seen. The low-hire, low-fire economy turns 3 years old.

MarketWatch · October 29, 2026

Is it dumb to take travel advice from influencers?

MarketWatch · October 29, 2026

Most read